Open-label trial of aripiprazole in the treatment of trichotillomania

Journal of Clinical Psychopharmacology

Volumn 31, Issue 4, 2011, Pages 503-506

  White, Matthew P ^a   Koran, Lorrin M ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

aripiprazole; impulse control disorder; pharmacology; treatment; trichotillomania

Indexed keywords

ARIPIPRAZOLE;

ADULT; AGED; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; DOUBLE BLIND PROCEDURE; FEMALE; GENERAL HOSPITAL; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; MOOD; OPEN STUDY; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; TRICHOTILLOMANIA; UNITED STATES;

ADULT; FEMALE; HUMANS; MIDDLE AGED; PIPERAZINES; PROSPECTIVE STUDIES; QUINOLONES; TREATMENT OUTCOME; TRICHOTILLOMANIA; YOUNG ADULT;

EID: 79960571107     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e318221b1ba     Document Type: Article

References (16)

1. Christenson GA, Pyle RL, Mitchell JE. Estimated lifetime prevalence of trichotillomania in college students. J Clin Psychiatry. 1991;52:415-417.
2. Woods DW, Flessner CA, Franklin ME, et al. The Trichotillomania Impact Project (TIP): exploring phenomenology, functional impairment, and treatment utilization. J Clin Psychiatry. 2006;67:1877-1888. (Pubitemid 46048185)
3. Swedo SE, Leonard HL, Rapoport JL, et al. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med. 1989;321:497-501. (Pubitemid 19203873)
4. Christenson GA, Mackenzie TB, Mitchell JE, et al. A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. Am J Psychiatry. 1991;148:1566-1571.
5. Streichenwein SM, Thornby JI. A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. Am J Psychiatry. 1995;152:1192-1196.
6. Ninan PT, Rothbaum BO, Marsteller FA, et al. A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in trichotillomania. J Clin Psychiatry. 2000;61:47-50. (Pubitemid 30104384)
7. Coric V, Kelmendi B, Pittenger C, et al. Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with trichotillomania. J Clin Psychiatry. 2007;68:170-171. (Pubitemid 46220144)
8. Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Arch Gen Psychiatry. 2009;66:756-763.
9. Van Ameringen M, Mancini C, Patterson B, et al. A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania. J Clin Psychiatry. 2010;2010:20.
10. Stein DJ, Hollander E. Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. J Clin Psychiatry. 1992;53:123-126.
11. Van Ameringen M, Mancini C, Oakman JM, et al. The potential role of haloperidol in the treatment of trichotillomania. J Affect Disord. 1999;56:219-226. (Pubitemid 30058226)
12. Senturk V, Tanriverdi N. Resistant trichotillomania and risperidone. Psychosomatics. 2002;43:429-430.
13. Khouzam HR, Battista MA, Byers PE. An overview of trichotillomania and its response to treatment with quetiapine. Psychiatry. 2002;65:261-270. (Pubitemid 35191283)
14. Kegeles LS, Slifstein M, Frankle WG, et al. Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride. Neuropsychopharmacology. 2008;33:3111-3125.
15. Mamo D, Graff A, Mizrahi R, et al. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study. Am J Psychiatry. 2007;164:1411-1417. (Pubitemid 47461142)
16. Grant JE, Kim SW, Odlaug BL. N-acetyl cysteine, a glutamate-modulating agent, in the treatment of pathological gambling: a pilot study. Biol Psychiatry. 2007;62:652-657. (Pubitemid 47314380)